Susceptibility of extended-spectrum-β-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3127-3131

  Wang, Peng ^a   Hu, Fupin ^a   Xiong, Zizhong ^c   Ye, Xinyu ^a   Zhu, Demei ^a   Wang, Yun F ^d   Wang, Minggui ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLACTX M GENE; BLASHV GENE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS;

ANTI-BACTERIAL AGENTS; AZTREONAM; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HOSPITALS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PROTEUS MIRABILIS;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; PROTEUS MIRABILIS;

EID: 80052202335     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00222-11     Document Type: Article

References (34)

1. Ardanuy, C., et al. 1998. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1636-1640.
2. Babini, G. S., and D. M. Livermore. 2000. Are SHV β-lactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother. 44:2230.
3. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
4. Cantón, R., et al. 2008. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl. 1):144-153.
5. Cao, B., et al. 2006. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli. Diagn. Microbiol. Infect. Dis. 56:351-357.
6. Chen, H. Y., et al. 1993. Multicentre survey of the in-vitro activity of piperacillin/ tazobactam against bacteria from hospitalized patients in the British Isles. J. Antimicrob. Chemother. 32:247-266.
7. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement (M100-S20). Clinical and Laboratory Standards Institute, Wayne, PA.
9. Dumarche, P., et al. 2002. TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46:1128-1131.
10. Hawkey, P. M. 2008. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl. 1):159-165.
11. Hawkey, P. M., and A. M. Jones. 2009. The changing epidemiology of resistance. J. Antimicrob. Chemother. 64(Suppl. 1):i3-i10.
12. Hernández-Allés, S., et al. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273-277.
13. Jacoby, G. A. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182.
14. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum betalactamases. Antimicrob. Agents Chemother. 35:1697-1704.
15. Kang, C. I., et al. 2004. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob. Agents Chemother. 48:4574-4581.
16. Liu, W., et al. 2009. Novel CTX-M β-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, southern China. J. Antimicrob. Chemother. 63:895-900.
17. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
18. Martínez-Martínez, L., et al. 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669-1673.
19. Mendonca, N., et al. 2007. Spread of extended-spectrum β-lactamase CTX-M- producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 51:1946-1955.
20. Munier, G. K., et al. 2010. Positive extended-spectrum-β-lactamase (ESBL) screening results may be due to AmpC β-lactamases more often than to ESBLs. J. Clin. Microbiol. 48:673-674.
21. Reference deleted.
22. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
23. Paterson, D. L., et al. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39:2206-2212.
24. Perez, F., A. Endimiani, K. M. Hujer, and R. A. Bonomo. 2007. The continuing challenge of ESBLs. Curr. Opin. Pharmacol. 7:459-469.
25. Reference deleted.
26. Pitout, J. D. D., A. Hossain, and N. D. Hanson. 2004. Phenotypic and molecular detection of CTX-M β-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 42:5715-5721.
27. Pitout, J. D. D., et al. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15- producing isolates. Antimicrob. Agents Chemother. 51:1281-1286.
28. Qureshi, Z. A., et al. 2011. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. Int. J. Antimicrob. Agents 37:26-32.
29. Sharp, S., K. Bennett, and A. Coover. 2009. CLSI modified cephalosporin breakpoints will not detect all ESBL-producing Enterobacteriaceae as compared to currently recommended CLSI confirmatory testing, abstr. D-734. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
30. Smith Moland, E., J. A. Black, N. D. Hanson, and K. S. Thomson. 2009. Concerns about ESBL testing in 2010, abstr. D-728. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
31. Wang, F., et al. 2010. CHINET 2009 surveillance of bacterial resistance in China. Chin. J. Infect. Chemother. 9:325-334.
32. Woodford, N., E. J. Fagan, and M. J. Ellington. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154-155.
33. Xiong, Z., et al. 2002. Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn. Microbiol. Infect. Dis. 44:195-200.
34. Yu, Y., et al. 2007. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J. Infect. 54:53-57. (Pubitemid 44932943)